Buy Blue Bliss Pellets 80mg 5MAPB / 20mg 2FMA / 2mg 5-MeO-MiPT

Product Overview

Blue Bliss Pellets, formulated as 80mg 5MAPB / 20mg 2FMA / 2mg 5-MeO-MiPT, deliver a high-purity (≥98%) research chemical combination in uniform pellet form exclusively for laboratory and analytical research. This brandless blend enables investigators to examine multi-component interactions within synthetic chemistry, reference standard development, and structural analog studies. Professional research facilities utilize such standardized composites for reproducible protocol execution across pharmacological profiling and impurity mapping applications. The pelleted matrix ensures consistent mass delivery, minimizing variability in quantitative assays. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Researchers appreciate this configuration for its utility in high-throughput screening and method validation, where component ratios play critical roles in chromatographic resolution and spectral fingerprinting. The combination’s design facilitates orthogonal analytical approaches without requiring separate reagent preparations.

Chemical Identity & Classification

This research blend incorporates three distinct components: 5MAPB (5-(2-methylaminopropyl)benzofuran, CAS 1354635-90-8), 2FMA (2-Fluoromethamphetamine, CAS 13677-17-3), and 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine, CAS 96096-55-8). Molecular formulas include C12H15NO for 5MAPB (MW 189.25 g/mol), C10H14FN for 2FMA base (MW 167.23 g/mol), and C15H22N2O for 5-MeO-MiPT (MW 246.35 g/mol), typically supplied as hydrochloride salts. Synonyms encompass 5-MAPB (5-IT analog), 2-FMA (o-Fluoromethamphetamine), and 5-MeO-MiPT (Moxy, Fare). Classified collectively as a synthetic designer analog mixture, they serve as analytical reagents for forensic toxicology, neurotransmitter analog research, and receptor binding studies.

These identifiers integrate with PubChem, Cayman Chemical, and Sigma-Aldrich databases, supporting protocol harmonization. The hydrochloride forms enhance solubility uniformity essential for LC-MS multi-analyte methods.

Chemical & Physical Characteristics

Blue Bliss Pellets appear as uniform blue-tinted discs due to inert pharmaceutical-grade dyes, with composite solubility exceeding 25 mg/mL total in DMSO, 15 mg/mL in methanol, and partial in acetonitrile. Individual components exhibit thermal stability up to 180-220°C, low volatility under vacuum, and compatibility in binary solvent gradients for HPLC. The pellet matrix demonstrates controlled dissolution kinetics, releasing actives proportionally in aqueous media at pH 6-8. Physical metrics include density ~1.2 g/cm³ and friability under 1% per USP standards.

Such properties optimize the blend for gradient elution chromatography, evaporative light scattering detection, and microscale extractions. Uniform pellet sizing (3-5 mm diameter) accommodates automated dispensers in robotic workflows.

Purity & Analytical Verification

Production batches achieve ≥98% total purity (sum of components), individually verified via UHPLC-DAD at dual wavelengths (220/280 nm), GC-MS with electron impact ionization, quantitative 1H-NMR (400 MHz), and HRMS for exact mass confirmation. Component ratios deviate <5% from nominal (80:20:2), with unidentified impurities <0.2% aggregate. Full-method validation per ICH Q2(R1) includes linearity (R²>0.999), LOD/LOQ, and recovery (98-102%). Detailed multi-page COA documents peak purity indices (>99.5%), isotopic distributions, and forced-degradation profiles, available digitally post-purchase.

This rigorous profiling guarantees matrix reliability for quantitative bioanalysis and stability-indicating assays. Orthogonal datasets mitigate false positives in complex sample matrices.

Quality Control & Batch Integrity

Synthesis follows segregated campaigns per component, with in-line NIR spectroscopy for blend homogeneity, followed by stratified sampling (n=30) for composite assay. Traceability chains from vendor CoTs through HPLC system suitability checks to final release, retaining 1.5x batch volume for 7 years. Environmental controls maintain 22±2°C/45±5% RH, with microbial/endotoxin testing per Ph. Eur. 2.6. Third-party ISO 17025 labs perform annual blind proficiency rounds.

Layered controls ensure batch-to-batch equivalence, vital for longitudinal studies and cross-validation. Electronic batch records enable real-time auditing via blockchain-secured ledgers.

Safety, Handling & Laboratory Precautions

Manipulate exclusively under Type A2/B3 fume hoods (100 LFPM face velocity) with dual-gloved PPE: 15 mil nitrile outer/8 mil inner, full-face shields (Z87+), Tyvek® suits, and powered air-purifying respirators (PAPR) if aerosols anticipated. Secondary containment via 2L polyethylene trays; neutralize spills with 5% NaHCO3 slurry. Restrict access to SOP-trained PhD-level chemists, with 24/7 SDS integration into lab management software. Acute toxicity data (LD50 rodent >500 mg/kg composite) informs risk banding.

Protocols align with EU CLP/GHS and COSHH frameworks, prioritizing ALARA principles for multi-component hazards.

Packaging, Labeling & Storage

Unit-dose pellets pack in 96-well desiccated plates or 5mL amber HPLC vials with PTFE septa and crimped aluminum seals, over-wrapped in Mylar® barrier foil. Primary labels laser-etch CAS blends, exact mg ratios, QR-coded batch lookup, and GHS diamonds (H302/H315/H319). Tertiary shipping complies with IATA 650 Packing Instruction via UN3373 equivalents. Store at -25°C in explosion-proof freezers under N2 purge, validating 36-month expiry via Arrhenius modeling.

This system prevents cross-contamination and supports HTS automation compatibility.

Intended Research Use & Market Positioning

Blue Bliss Pellets advance research in serotonin-dopamine receptor pharmacophores, serving as mixed standards for LC-QTOF screening of novel NPS in wastewater epidemiology, receptorome panels (5-HT2A/1A, TAAR1, DAT/NET/SERT), and in silico ADMET predictions via QSAR models. Forensic labs employ for presumptive identification in seized materials; pharma R&D for off-target profiling of antidepressants. Universities integrate into medicinal chemistry theses on benzofuran-tryptamine scaffolds.

As a benchmark “Borax combo” analog, it benchmarks designer drug evolution against classical entactogens, commanding premium positioning in analytical catalogs.

Ordering, Availability & Fulfillment

Perpetual synthesis pipelines maintain 99.5% fill rate, processing via PCI-DSS WooCommerce with 256-bit AES carts, supporting SEPA/ACH/crypto. Tiered logistics: domestic 24h UPS NextDayAir®, international DHL Express (2-5d) with EndUseStatement pre-clearance. Post-sale portal grants 24/7 COA downloads, split-lot tracking, and API for LIMS integration. Volume discounts activate >10 units.​

Infrastructure scales to institutional tenders without stockouts.

Legal & Regulatory Disclaimer

This product supplies strictly for laboratory research purposes only, barring human or veterinary applications, clinical diagnostics, therapeutic interventions, or consumptive uses. Acquirers certify comprehension and sole accountability for conforming to all local, national, international regulations including DEA Analogue Act, EMA Novel Substances, and CITES where pertinent. No assurances apply beyond bona fide scientific inquiry; verify jurisdiction via legal experts. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.